The Magazine for Sleep Professionals
Saturday, September 19, 2026
According to a recent Qualtrics Survey conducted September 4th through September 11th, of over 200 respondents with mild to moderate sleep apnea, more than 70% said they would prefer to try the FDA cleared Bongo Rx over traditional CPAP therapy to treat their sleep apnea when given the choice. The Bongo […]
The AirAvant Medical team is looking forward to sharing their poster findings with the attendees at the SLEEP 2019 conference in San Antonio on June 8-12. The opportunity to engage with industry experts, doctors, and providers is sure to generate even more clinical interest in using the Bongo Rx, an […]
AirAvant Medical is proud to announce that its flagship product, FDA Cleared Bongo Rx, is now available for patients requiring treatment of mild to moderate obstructive sleep apnea (OSA). Years of painstaking research, development, and testing have yielded a device that is small, portable, and best of all requires no […]
